145 related articles for article (PubMed ID: 5450187)
1. Plasma thyrotropin (TSH) and long-acting thyroid stimulator (LATS) in patients treated for thyroid carcinoma.
Valenta L; Lemarchand-Béraud T; Vannotti A
Eur J Cancer (1965); 1970 Apr; 6(2):139-43. PubMed ID: 5450187
[No Abstract] [Full Text] [Related]
2. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
3. Clinical significance of LATS and TSH in the blood.
Lemarchand-Béraud T; Griessen M; Scazziga BR
Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
[No Abstract] [Full Text] [Related]
4. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
5. [Long-acting thyroid stimulator (LATS) in thyroid pathology].
Winand R
Rev Med Liege; 1970 Aug; 25(15):478-82. PubMed ID: 5468466
[No Abstract] [Full Text] [Related]
6. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
Noguchi A; Kurihara H; Ozeki Y; Sato S
Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
[No Abstract] [Full Text] [Related]
7. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
Mertz DP; Stelzer M
Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
[No Abstract] [Full Text] [Related]
8. [Hormonogenesis in thyroid neoplasms].
Valenta L; Lemarchand-Béraud T; Vannotti A; Silink K
Schweiz Med Wochenschr; 1968 Jan; 98(4):101-10. PubMed ID: 5670492
[No Abstract] [Full Text] [Related]
9. [EFFECT OF THE ADMINISTRATION OF THE THYROID HORMONE ON THE LEVELS OF TSH AND LATS IN THE SERUM OF THE THYROID PATIENTS].
SAKAGAMI A
Nihon Naika Gakkai Zasshi; 1964 Feb; 52():1317-22. PubMed ID: 14156206
[No Abstract] [Full Text] [Related]
10. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
Lamberg BA; Gordin A; Viherkoski M; Kvist G
Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
[No Abstract] [Full Text] [Related]
11. [The long-acting thyroid stimulator (LATS) in untreated and I-131 treated hyperthyreoses, following total thyroidectomy, as well as its relation to thyroid antibodies].
Ziemke A; Weisbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W
Klin Wochenschr; 1968 Oct; 46(19):1025-7. PubMed ID: 5727481
[No Abstract] [Full Text] [Related]
12. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
13. Plasma thyrotrophin levels in thyroid disease and effect of treatment.
Lemarchand-Béraud T; Scazziga BR; Vannotti A
Acta Endocrinol (Copenh); 1969 Dec; 62(4):593-606. PubMed ID: 4188440
[No Abstract] [Full Text] [Related]
14. The need for more sensitive assays for the measurement of thyroid-stimulating hormone (TSH) and the long-acting thyroid stimulator (LATS).
Hall R
Clin Endocrinol (Oxf); 1974 Jul; 3(3):361-2. PubMed ID: 4837955
[No Abstract] [Full Text] [Related]
15. THE EFFECT OF THYROID HORMONE ON THE LEVELS OF THYROTROPIN (TSH) AND LONG-ACTING THYROID STIMULATOR (L.A.T.S.) IN THYROID DISORDERS.
SAKAGAMI A; FUKUCHI M; MASUI H; MIYAI K; IWATSUBO H; KUMAHARA Y; YOSHIDA T
Med J Osaka Univ; 1964 Mar; 14():235-44. PubMed ID: 14195720
[No Abstract] [Full Text] [Related]
16. [The simultaneous presence of TSH and LATS in plasma. Selective study done by using anti-TSH serum to measure the thyrotropic activity biologically].
Tourniaire J; Durand H; Orgiazzi J; Mornex R
Lyon Med; 1971 Sep; 226(14):163-6. PubMed ID: 5171130
[No Abstract] [Full Text] [Related]
17. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
18. [Discrepancy between the basal level of TSH and the thyrotropic response to TRH during thyroid hormone treatment of differentiated thyroid cancers].
Charrie A; Tourniaire J; Bernard MH; Dutey P; Andrianasolo H; Fleury-Goyon MC
Ann Endocrinol (Paris); 1989; 50(1):31-5. PubMed ID: 2499241
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
20. [Isolation of long acting thyroid stimulator (LATS) and thyroid stimulating hormone (TSH) in the serum].
Ochi Y; Shiomi K; Yatani T; Yoshimura M; Miyazaki T
Horumon To Rinsho; 1973 Jan; 21(1):49-52. PubMed ID: 4736415
[No Abstract] [Full Text] [Related]
[Next] [New Search]
